Go offline with the Player FM app!
Biotech Course Correction With Treehill Partners' Ali Pashazadeh
Manage episode 442760715 series 2739469
We love to hear from our listeners. Send us a message.
It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it's a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh's no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you're a biotech builder in the throes of disruption, or feeling lucky that you've been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Chapters
1. Biotech Course Correction With Treehill Partners' Ali Pashazadeh (00:00:00)
2. Ali Ashazadeh (00:00:04)
3. Medical Doctor Turned Investment Banker (00:14:19)
4. Improving Drug Development Decision-Making (00:26:02)
5. Optimizing Drug Development Decision-Making (00:35:38)
6. Navigating External Influences in Biotech (00:46:01)
7. Navigating Emotional Challenges in Biotech (01:01:07)
8. The Importance of Clinical Trial Disclosure (01:10:35)
222 episodes
Manage episode 442760715 series 2739469
We love to hear from our listeners. Send us a message.
It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it's a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh's no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you're a biotech builder in the throes of disruption, or feeling lucky that you've been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.
Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com
Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
Chapters
1. Biotech Course Correction With Treehill Partners' Ali Pashazadeh (00:00:00)
2. Ali Ashazadeh (00:00:04)
3. Medical Doctor Turned Investment Banker (00:14:19)
4. Improving Drug Development Decision-Making (00:26:02)
5. Optimizing Drug Development Decision-Making (00:35:38)
6. Navigating External Influences in Biotech (00:46:01)
7. Navigating Emotional Challenges in Biotech (01:01:07)
8. The Importance of Clinical Trial Disclosure (01:10:35)
222 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.